Conclusion: All antidepressants were more efficacious than placebo in adults with major depressive disorder. Smaller differences between active drugs were found when placebo-controlled trials were included in the analysis, whereas there was more variability in efficacy and acceptability in head-to-head trials. These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants.
PubMed 29477251 ↗Fluoxetine
Also known as Prozac
The short answer. Most people who report on Fluoxetine say it did not help (only 26% of 73 positive). It is most often used for mood: 65% of 48 reports say that improved. It is well studied — 534 meta-analyses on PubMed. The most common complaint is sexual dysfunction.
From 119 mentions in total — the rest didn't say how it went and aren't counted.
What Fluoxetine does, according to users
Of the people who reported each effect, the share who said it got better.
5 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 534 meta-analyses on PubMed ↗ · 1,257 randomized trials ↗
Conclusion: According to the available evidence, the combination of a selective serotonin reuptake inhibitor and a second-generation antipsychotic-and particularly of fluoxetine and olanzapine-could be the optimal treatment choice for psychotic depression. These findings should be taken into account in the development of clinical practice guidelines. However, these conclusions should be interpreted cautiously in view of the low number of included studies and the limitations of these studies.
PubMed 38360024 ↗Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.
PubMed 30712879 ↗Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.
PubMed 36253442 ↗386 human trials on ClinicalTrials.gov test Fluoxetine — 245 completed, 33 recruiting now. See all on ClinicalTrials.gov ↗
- A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression · Outpatients / Inpatients With Depression · 2024
- Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants · Depression, Inflammation · 2026
- Comparison of Efficacy of Minocyclin and Celecoxib as Adjunctive Treatment in Treatment Resistant Cases of Major Depressive Disorder · Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD) · 2023
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age…”
The FDA found Fluoxetine as an undeclared ingredient in 24 products sold as supplements, most recently on 2026-06-04. FDA tainted-products database ↗
11 recalls of products named for Fluoxetine. Most recent:
- 2025-06-11 · Class II: CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit. record ↗
- 2018-02-21 · Class III: Failed impurities/ degradation specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling all lots within expiry due to out of specification… record ↗
- 2015-05-06 · Class II: Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological… record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
131,827 adverse-event reports mention Fluoxetine. Most often reported:
- Drug ineffective · 8,387
- Nausea · 7,747
- Fatigue · 7,712
- Headache · 6,584
- Depression · 6,131
- Anxiety · 5,974
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Fluoxetine C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗
NIH has funded 65 research projects with Fluoxetine in the title, $58,138,520 in total (1985–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Fluoxetine ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“20mg or Prozac and 50 mg twice a day for my depression, anxiety, and mood swings. It works.”
“Prozac at 21 stole most of my libido. Found myself getting into riskier situations to feel the rush of desire I used to have much more organically.”
“SSRI (Prozac) was amazing for me while I was a teen. No longer need it but I went from wanting to kill myself every second of the day to feeling tolerable.”
“I truly felt mine truly kicking in 4-6 months down the line.”
Top discussions (5)
- Magnesium. Was it really That simple this WHOLE TIME!?!? ↗
- In a study of young men (average age of 27) experiencing Post-SSRI Sexual Dysfunction, the average erectile function score was consistent with severe ED. Ultrasound findings indicated that the penile tissue of these young men resembled that of men in their mid-60s. ↗
- People who want to start taking SSRIs or other antidepressants must be aware of this!! ↗
- Do any of you think we’re just spinning in circles? ↗
- Prolonged Remission of Major Depressive Disorder After Single Nitrous Oxide [laughing gas] Inhalation Treatment | 1h long inhalation dropped depression scale to 0 and lasted for >1 month ↗
Fluoxetine compared
Other options for mood
Sources
- User reports: 119 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- FDA tainted-products database ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate